Patients with acute hepatitis C virus (HCV) infection appear to have an excellent chance of responding to 6 months of standard therapy with interferon (IFN). Because spontaneous resolution is common, no definitive timing of therapy initiation can be recommended; however, waiting 2-4 months after the onset of illness seems reasonable. Patients with advanced fibrosis, those with compensated cirrhosis, liver transplant recipients, and those with severe extraheptic hepatitis are to be given the highest priority for treatment
Based on available resources, patients at high risk for liver-related complications and severe extrahepatic hepatitis C complications should be given high priority for treatment Treatment decisions should balance the anticipated reduction in transmission versus the likelihood of reinfection in patients whose risk of HCV transmission is high and in whom HCV treatment may result in a reduction in transmission eg, men who have high-risk sex with men, active injection drug users, incarcerated persons, and those on hemodialysis.
Unfortunately, there is no vaccine to prevent hepatitis C. To reduce your risk of getting hepatitis C: Do not inject drugs. If you do inject drugs, stop and get into a treatment program. If you can't stop, never share needles, syringes, water, or "works
Treatment with a combination of antiviral medicines can fight the viral infection and prevent serious liver problems like cirrhosis or liver cancer. They are used for 12 weeks to a year and help your body get rid of the virus.
Whether or not you take medicines to treat hepatitis C, you will need to have routine blood tests to help your doctor know how well your liver is working.
Some people who at first decide not to have treatment later decide they want to have it.
Your doctor can help you decide whether medicines are right for you.